Table 2.
Laboratory data of the 9 previously reported cases and of the authors' patient with renal wasting hypophosphatemia associated with SCC
Patient number | Serum phosphorus (mg/dL) (N: 2.5–4.5) | TmP/GFR (mg/dL) | Serum sodium (mEq/L) | Serum cortisol (µg/dL) | ||
Initial | After tumor treatment | Initial | After tumor treatment | |||
2 | 2.2 | 3.4 | NA | 132 | 141 | NA |
3 | 1.9 | 2.7 | NA | NA | NA | NA |
4 | 1.36 | 1.55 | 0.8 | NA | NA | NA |
4 | 1.95 | 3.75 | 1.1 | NA | NA | NA |
5 | 1.5 | NA | Very low | 113 | No | 21 (AM) |
6 | 1.2 | Still low | NA | 107- | 138 | 17.3 |
Authors' Patient | 1.2 | 4.5 | 0.6 | 117 | 127 | 29.4 (AM) |
7 | 0.84 | NA | 0.4 | 117 | NA | NA |
8 | 0.99 | 1.08 | 0.5 | 143 | 143 | 45.38 at 9 am |
9 | 1.2 | 4.3 -> 1.2–2.8 | 1.40 | 107 | Corrected and recurrence | 35 |
NA = Not available